Citigroup Inc Kamada LTD Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Kamada LTD stock. As of the latest transaction made, Citigroup Inc holds 300 shares of KMDA stock, worth $1,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300

Previous 300 -0.0%

Holding current value

$1,770

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$5.58 - $6.42 $1,674 - $1,926	300 New	300 $1,000
Q4 2022 Feb 09, 2023	SELL	$3.79 - $4.84 $56,546 - $72,212	-14,920 Reduced 99.99%	2 $0
Q3 2022 Nov 10, 2022	BUY	$4.42 - $5.43 $62,958 - $77,344	14,244 Added 2100.88%	14,922 $66,000
Q2 2022 Aug 10, 2022	SELL	$4.22 - $5.85 $153,017 - $212,121	-36,260 Reduced 98.16%	678 $3,000
Q1 2022 May 12, 2022	BUY	$5.43 - $6.81 $193,199 - $242,299	35,580 Added 2620.03%	36,938 $206,000
Q4 2021 Feb 10, 2022	SELL	$5.21 - $6.82 $6,001 - $7,856	-1,152 Reduced 45.9%	1,358 $9,000
Q3 2021 Nov 10, 2021	BUY	$5.25 - $5.87 $13,177 - $14,733	2,510 New	2,510 $13,000

Others Institutions Holding KMDA

# of Institutions

Shares Held

6.48M

Call Options Held

200

Put Options Held

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account